Role of a Novel Corepressor in Nuclear Receptor Action
新型辅阻遏物在核受体作用中的作用
基本信息
- 批准号:7100498
- 负责人:
- 金额:$ 29.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-05 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The long term goal of this work is to understand how gene regulatory networks controlled by hormones regulate developmental and physiological processes. Nuclear receptors mediate the actions of a variety of hormones by activating the expression of specific genes. Some nuclear receptors can also repress transcription by association with corepressors, but less is known about the mechanisms and significance of repression. This study focuses on a novel nuclear receptor corepressor, the protein encoded by the mammalian Hairless (Hr) gene. This laboratory has demonstrated that the Hairless (HR) protein influences the function of multiple nuclear receptors, including thyroid hormone receptors, vitamin D receptor, and an orphan receptor, ROR. HR functions in many tissues, most prominently in skin as mutations in the Hr gene cause (alopecia) hair loss in humans and mice. Our central hypothesis is that HR influences the expression of downstream hormone-responsive genes in vivo, and that the Hr mutant phenotype arises from specific changes in gene expression. One goal of the proposed research is to determine the molecular mechanisms by which HR acts as a transcriptional represser, and will include the identification of specific proteins, including other nuclear receptors, that interact with HR. Defining the signaling pathways influenced by HR will include the identification of specific target genes that are regulated by HR; based on our recent data, candidate target genes include specific inhibitors of Wnt signaling. The Wnt signaling pathway plays an essential role in tissue development and homeostasis, and disruptions in Wnt signaling are associated with cancer. A second goal is to test HR function in vivo using genetically engineered mice. Recent analysis of mice lacking HR expression has revealed a potential role in regulating stem cell differentiation, a model that will be tested using transgenic mice. Defining the role of HR using skin as a model system will provide insight into diverse biological processes, as HR also influences the activity of receptors that mediate brain development, bone formation and mineral metabolism. Nuclear receptors are already successful therapeutic targets for the treatment of diseases such as diabetes. Understanding the molecular pathway of HR corepressor action will help define a specific mechanism of regulating nuclear receptor function, which in turn may reveal potential sites of intervention to treat developmental and physiologic disorders. Hormones regulate biological processes such as growth and development via nuclear receptors. This work will allow us to understand a specific way of regulating nuclear receptor function, which should be useful for designing therapeutic agents for treating developmental and physiologic disorders.
描述(由申请人提供):这项工作的长期目标是了解激素控制的基因调控网络如何调节发育和生理过程。核受体通过激活特定基因的表达来介导多种激素的作用。一些核受体也可以通过与辅阻遏物结合来抑制转录,但对抑制的机制和意义知之甚少。本研究的重点是一种新的核受体辅阻遏物,蛋白质编码的哺乳动物无毛(Hr)基因。该实验室已经证明,无毛(HR)蛋白影响多种核受体的功能,包括甲状腺激素受体,维生素D受体和孤儿受体ROR。HR在许多组织中起作用,最突出的是在皮肤中,因为Hr基因的突变导致人类和小鼠的脱发。我们的中心假设是,HR影响下游的表达,应答基因在体内,和HR突变表型产生的基因表达的特定变化。这项研究的目标之一是确定HR作为转录抑制因子的分子机制,并将包括鉴定与HR相互作用的特定蛋白质,包括其他核受体。基于我们最近的数据,候选靶基因包括Wnt信号传导的特异性抑制剂。Wnt信号通路在组织发育和体内平衡中起着重要作用,并且Wnt信号通路的破坏与癌症相关。第二个目标是使用基因工程小鼠在体内测试HR功能。最近对缺乏HR表达的小鼠的分析揭示了在调节干细胞分化中的潜在作用,这是一种将使用转基因小鼠进行测试的模型。使用皮肤作为模型系统来定义HR的作用将提供对不同生物过程的深入了解,因为HR还影响介导大脑发育、骨形成和矿物质代谢的受体的活性。核受体已经是治疗糖尿病等疾病的成功治疗靶点。了解HR辅阻遏物作用的分子途径将有助于确定调节核受体功能的特定机制,这反过来可能揭示治疗发育和生理障碍的潜在干预位点。激素通过核受体调节生物过程,如生长和发育。这项工作将使我们能够了解一个特定的方式来调节核受体的功能,这应该是有用的设计治疗药物治疗发育和生理障碍。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CATHERINE C THOMPSON其他文献
CATHERINE C THOMPSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CATHERINE C THOMPSON', 18)}}的其他基金
Role of Mammalian Hairless Gene in Neural Development
哺乳动物无毛基因在神经发育中的作用
- 批准号:
6639738 - 财政年份:2001
- 资助金额:
$ 29.52万 - 项目类别:
Role of Mammalian Hairless Gene in Neural Development
哺乳动物无毛基因在神经发育中的作用
- 批准号:
6743762 - 财政年份:2001
- 资助金额:
$ 29.52万 - 项目类别:
Role of Mammalian Hairless Gene in Neural Development
哺乳动物无毛基因在神经发育中的作用
- 批准号:
6540402 - 财政年份:2001
- 资助金额:
$ 29.52万 - 项目类别:
Role of Mammalian Hairless Gene in Neural Development
哺乳动物无毛基因在神经发育中的作用
- 批准号:
6318164 - 财政年份:2001
- 资助金额:
$ 29.52万 - 项目类别:
TARGETS OF THYROID HORMONE ACTION IN DEVELOPING BRAIN
甲状腺激素在大脑发育中的作用目标
- 批准号:
2145283 - 财政年份:1995
- 资助金额:
$ 29.52万 - 项目类别:
TARGETS OF THYROID HORMONE ACTION IN DEVELOPING BRAIN
甲状腺激素在大脑发育中的作用目标
- 批准号:
2882777 - 财政年份:1995
- 资助金额:
$ 29.52万 - 项目类别:
TARGETS OF THYROID HORMONE ACTION IN DEVELOPING BRAIN
甲状腺激素在大脑发育中的作用目标
- 批准号:
2377804 - 财政年份:1995
- 资助金额:
$ 29.52万 - 项目类别:
TARGETS OF THYROID HORMONE ACTION IN DEVELOPING BRAIN
甲状腺激素在大脑发育中的作用目标
- 批准号:
2668308 - 财政年份:1995
- 资助金额:
$ 29.52万 - 项目类别:
TARGETS OF THYROID HORMONE ACTION IN DEVELOPING BRAIN
甲状腺激素在大脑发育中的作用目标
- 批准号:
2145284 - 财政年份:1995
- 资助金额:
$ 29.52万 - 项目类别:
相似国自然基金
Laminin-511在非瘢痕性脱发疾病中的作用
- 批准号:81101206
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Pre-clinical testing of low intensity ultrasound as novel strategy to prevent paclitaxel-induced hair follicle damage in a humanized mouse model of chemotherapy-induced alopecia
低强度超声的临床前测试作为预防化疗引起的脱发人源化小鼠模型中紫杉醇引起的毛囊损伤的新策略
- 批准号:
10722518 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Role of cytosolic DNA-induced sterile inflammation driving cellular and organismal progeria/aging hallmarks
细胞质 DNA 诱导的无菌炎症在驱动细胞和机体早衰/衰老标志中的作用
- 批准号:
10901042 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Influence of the Microbiome on the Natural History of Alopecia Areata
微生物组对斑秃自然史的影响
- 批准号:
10585677 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Knowledge Engine- A computational approach to combatting dermatological health disparities in underserved communities
知识引擎 - 一种解决服务不足社区皮肤病健康差异的计算方法
- 批准号:
10697912 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Developing a programmable siRNA-based therapeutic platform for gene silencing in the skin
开发基于 siRNA 的可编程治疗平台,用于皮肤基因沉默
- 批准号:
10723917 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Vitiligo topical treatment applying a potent, highly selective MC1R agonist
使用强效、高选择性 MC1R 激动剂进行白癜风局部治疗
- 批准号:
10759768 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Development of a Novel, Targeted Small Molecule Inhibitor of the Nucleoside Salvage Pathway to Treat Systemic Lupus Erythematosus
开发一种新型核苷挽救途径靶向小分子抑制剂来治疗系统性红斑狼疮
- 批准号:
10755905 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Pathogenic T cells in discoid lupus erythematosus
盘状红斑狼疮中的致病性 T 细胞
- 批准号:
10664134 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Development of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus.
开发用于局部治疗红斑狼疮皮肤表现的内源性大麻素微粒制剂。
- 批准号:
10699531 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Scalp cooling for the prevention of chemotherapy-induced alopecia: increasing patient access through eco-design and innovative manufacturing.
头皮冷却预防化疗引起的脱发:通过生态设计和创新制造增加患者接触机会。
- 批准号:
10014407 - 财政年份:2022
- 资助金额:
$ 29.52万 - 项目类别:
Collaborative R&D














{{item.name}}会员




